Regeneron Pharmaceuticals (REGN) Change in Inventory (2013 - 2026)
Regeneron Pharmaceuticals (REGN) posted quarterly Change in Inventory of $28.2 million for Q2 2026, down 33.65% year-over-year from $42.5 million in Q2 2025, and up 206.02% quarter-over-quarter from -$26.6 million in Q1 2026.
Regeneron Pharmaceuticals (REGN) Change in Inventory (2013 - 2026) Analysis & Trends
Regeneron Pharmaceuticals' Change in Inventory history runs 14 years deep, the most recent figure standing at $28.2 million for Q2 2026.
- In Q2 2026, Change in Inventory fell 33.65% year-over-year to $28.2 million; the TTM figure through Jun 2026 stood at $82.1 million (down 82.78% YoY), while the FY2025 annual figure was $275.3 million, down 55.58% from the prior year.
- Change in Inventory for Q2 2026 stood at $28.2 million, up from -$26.6 million in the prior quarter.
- The five-year high for Change in Inventory was $240.1 million in Q2 2022, with the low at -$26.6 million in Q1 2026.
- The 5-year median for Change in Inventory is $94.5 million (2022), against an average of $103.6 million.
- The sharpest annual moves came in 2022 and 2026: Change in Inventory surged 867.09% in 2022, then tumbled 117.47% in 2026.
- Regeneron Pharmaceuticals' Change in Inventory stood at $144.3 million in 2022, then slumped by 67.22% to $47.3 million in 2023, then soared by 148.84% to $117.7 million in 2024, then plunged by 101.78% to -$2.1 million in 2025, then surged by 1442.86% to $28.2 million in 2026.
- Business Quant data shows REGN's Change in Inventory at $28.2 million in Q2 2026, -$26.6 million in Q1 2026, and -$2.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.20 Mn |
| Jun 30, 2026 | 28.20 Mn |
| Mar 31, 2026 | -26.60 Mn |
| Mar 31, 2026 | -26.60 Mn |
| Dec 31, 2025 | -2.10 Mn |
| Dec 31, 2025 | -2.10 Mn |
| Sep 30, 2025 | 82.60 Mn |
| Sep 30, 2025 | 82.60 Mn |
| Jun 30, 2025 | 42.50 Mn |
| Jun 30, 2025 | 42.50 Mn |
| Mar 31, 2025 | 152.30 Mn |
| Mar 31, 2025 | 152.30 Mn |
| Dec 31, 2024 | 117.70 Mn |
| Dec 31, 2024 | 117.70 Mn |
| Sep 30, 2024 | 164.40 Mn |
| Sep 30, 2024 | 164.40 Mn |
| Jun 30, 2024 | 181.80 Mn |
| Jun 30, 2024 | 181.80 Mn |
| Mar 31, 2024 | 155.80 Mn |
| Mar 31, 2024 | 155.80 Mn |